| 查看 |
ritonavir | 利托那韦 | J05AE03 | 2017-11-09 | Mylan S.A.S | Authorised |
| 查看 |
voriconazole | 伏立康唑 | J02AC03 | 2002-03-19 | Pfizer Europe MA EEIG | Authorised |
| 查看 |
tacrolimus | 他克莫司 | L04AD02 | 2009-05-15 | Astellas Pharma Europe B.V. | Authorised |
| 查看 |
tacrolimus | 他克莫司 | L04AD02 | 2007-04-23 | Astellas Pharma Europe B.V. | Authorised |
| 查看 |
olaparib | 奥拉帕尼 | L01XK01 | 2014-12-16 | AstraZeneca AB | Authorised |
| 查看 |
neratinib | 马来酸来那替尼 | L01EH02 | 2018-08-31 | Pierre Fabre Medicament | Authorised |
| 查看 |
sotrovimab | 索托韦单抗 | J06BD05 | 2021-12-17 | GlaxoSmithKline Trading Services Limited | Authorised |
| 查看 |
Tozinameran, COVID-19 mRNA Vaccine (nucleoside modified) | | J07BX | 2020-12-21 | BioNTech Manufacturing GmbH | Authorised |
| 查看 |
enfortumab vedotin | 维恩妥人单抗 | L01FX13 | 2022-04-13 | Astellas Pharma Europe B.V. | Authorised |
| 查看 |
tixagevimab, cilgavimab | | | 2022-03-25 | AstraZeneca AB | Authorised |
| 查看 |
tepotinib | | L01EX21 | 2022-02-16 | Merck Europe B.V. | Authorised |
| 查看 |
pregabalin | 普瑞巴林 | N03AX16 | 2017-02-27 | Zentiva k.s. | Authorised |
| 查看 |
fampridine | 氨吡啶 | N07XX07 | 2011-07-20 | Biogen Netherlands B.V. | Authorised |
| 查看 |
trametinib | 曲美替尼 | L01EE01 | 2014-06-30 | Novartis Europharm Limited | Authorised |
| 查看 |
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed) | | J07BM02 | 2007-09-20 | GlaxoSmithKline Biologicals S.A. | Authorised |
| 查看 |
emtricitabine, tenofovir disoproxil | 恩曲他滨;马来酸替诺福韦二吡呋酯 | J05AR03 | 2016-12-16 | Mylan Pharmaceuticals Limited | Authorised |
| 查看 |
arsenic trioxide | 三氧化二砷 | L01XX27 | 2019-11-14 | Accord Healthcare S.L.U. | Authorised |
| 查看 |
lisocabtagene maraleucel | | L01 | 2022-04-04 | Bristol-Myers Squibb Pharma EEIG | Authorised |
| 查看 |
cariprazine | 盐酸卡利拉嗪 | N05AX15 | 2017-07-13 | Gedeon Richter | Authorised |
| 查看 |
daridorexant | 奈莫雷生 | N05 | 2022-04-29 | Idorsia Pharmaceuticals Deutschland GmbH | Authorised |
